| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |